Applied Biotechnology Institute, Inc.

1:30 PM - 1:45 PM, Wednesday, June 5, 2019 ・ Theater 3
ABI has developed a platform for the high accumulation of recombinant proteins with unique advantages over existing technologies. This includes several applications including: 1) Using the platform to commercialized animal-free pharmaceutical reagents and industrial proteins, 2) Developing oral vaccines for both human and animals, 3) Developing a high intensity natural sweetener. The technology is also well suited to produce antibodies and other protein drugs for which proof-of concept has been demonstrated. ABI is now seeking partners to help commercialize products in the latter stages of development as well as initiate collaborations for new products with partners.
Ticker:
Not Provided.
Exchange:
Not Provided.
Company Type:
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2006
Main Therapeutic Focus:
Lead Product in Development:
Orally deliverred hepatitis vaccine
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
5
Speaker
photo
President
ABI